Please assess the completion status of the following clinical trial:

Trial Title: Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with Stage II pressure ulcer or greater~2. Patients who consent to participate~3. Patients who can ingest the supplement either orally or per feeding tube~4. Patients who are 21 years of age or older~Exclusion Criteria:~1. Patients with infected wounds~2. Patients with cellulitis, sepsis or osteomyelitis~3. Patients with end-organ failure~4. Patients with poorly controlled diabetes mellitus (HbA1C\>10)~5. Patients who cannot tolerate oral or bolus tube feedings

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Enriched product, dietary supplement (Type: EXPERIMENTAL): Subjects receiving enriched product compared to an unenriched product
- 1 (Type: ACTIVE_COMPARATOR): Subjects not receiving enriched product

Based on this trial design, predict the completion outcome and termination type (if applicable).